Search Orphan Drug Designations and Approvals
-
Generic Name: | Epoetin alfa |
---|---|
Date Designated: | 12/20/1993 |
Orphan Designation: | Treatment of myelodysplastic syndrome. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Johnson & Johnson Pharmaceutical Research & Dev., 920 U.S. Highway Route 202, P.O. Box 300 Raritan, New Jersey 08869 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-